Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ILIAD: Peginterferon Lambda for COVID-19
NCT04354259Phase 2Completed
- Sponsor
- University Health Network
- Start
- May 2020
- Primary completion
- Aug 2022
- Modality
- Cytokines & Interferons
- Countries
- 2
01
Overview
A Phase 2 trial of peginterferon lambda-1a in coronavirus disease 2019 (COVID-19), sponsored by University Health Network. Started May 2020; status: completed.
02
Drugs
peginterferon lambda-1a
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04354259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04354259.